We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Case report of penile cancer recurrence treated with cetuximab combined with anlotinib.
- Authors
Dai, Shuang; Liu, Yan‐Yang; Liu, Tao; Zhang, Yu; Luo, De‐Yun
- Abstract
Penile squamous cell carcinoma with pelvic lymph node metastases/recurrence has a poor prognosis. We reported a case with recurrent pSCC was administered cetuximab and anlotinib after failure of first‐line treatment and achieved an effective response. Cetuximab combined with anlotinib may be a new choice for relapsed pSCC.
- Subjects
PENILE cancer; CANCER relapse; CETUXIMAB; SQUAMOUS cell carcinoma; LYMPHATIC metastasis
- Publication
Clinical Case Reports, 2022, Vol 10, Issue 2, p1
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.5443